Clinical Trial Update: Study of Efficacy and Safety of LCZ696/Amlodipine in Grade 1 and 2 Hypertension Patients Uncontrolled by LCZ696 Monotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of adding amlodipine to LCZ696 (sacubitril/valsartan) in patients with Grade 1–2 hypertension uncontrolled by L…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• LCZ696 (sacubitril/valsartan) (sacubitril/valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 3 | Status: COMPLETED